Pharmacy benefit manager (“PBM”) audits have become a routine, but high-risk, part of operating an independent pharmacy. What many pharmacy owners underestimate, however, is how seemingly minor documentation errors can lead to significant exposure. PBMs increasingly scrutinize pharmacies not only for fraud or abuse, but for strict adherence to contractual, record-keeping, and billing requirements, and even small gaps in documentation can trigger recoupments and/or network terminations.

‍

PBMs such as Optum, CVS Caremark, and Express Scripts routinely audit pharmacy claims to confirm that reimbursements are fully supported by contemporaneous records. When documentation is incomplete, inconsistent, or unavailable, PBMs may determine that a claim lacks sufficient support and demand repayment. These determinations often result in substantial financial recoveries, even when the underlying issue stems from clerical oversights or record-keeping errors rather than improper dispensing or billing conduct.

‍

The financial impact of minor documentation issues is magnified by the increasingly rigid nature of PBM audit standards. PBMs frequently reject records they consider technically deficient, including missing patient signatures, incomplete refill documentation, inaccurate days’ supply entries, or gaps in inventory records. In many cases, audit findings are driven less by actual misconduct and more by discrepancies between a pharmacy’s internal records and the narrow documentation standards applied during retrospective review.

‍

Audits commonly flag issues such as missing original prescription records, inadequate proof of patient eligibility at the time of dispensing, lack of documentation confirming copayment collection, or inconsistencies between quantities billed and quantities reflected in inventory records. Even small variances in inventory reconciliation can lead a PBM to conclude that more medication was billed than purchased or dispensed, frequently resulting in recoupment demands regardless of intent or explanation.

‍

PBMs generally do not treat these issues as harmless technicalities. Instead, documentation lapses are often characterized as compliance failures that justify financial adjustment, corrective action requirements, or escalated enforcement. As a result, pharmacies must operate with the understanding that documentation created today may be scrutinized months or years later under strict audit standards. Precision, consistency, and accessibility of records are essential to protecting reimbursement and network participation.

When documentation deficiencies form the basis of audit findings, pharmacies may face recoupments, offsets against future payments, or repayment demands that materially impact cash flow. Repeated or unresolved findings can also escalate into broader compliance actions, including threats to continued network participation.

‍

This reality underscores the importance of proactive compliance. Pharmacies that maintain audit-ready documentation, conduct regular internal self-audits, and train staff on evolving PBM requirements are far better positioned to respond effectively when an audit occurs. Just as importantly, experienced PBM audit defense counsel can help pharmacies analyze audit findings, identify defensible positions, and pursue contractual appeal rights to reduce or eliminate financial exposure.

How Health Law Alliance Can Help

Health Law Alliance regularly represents pharmacies nationwide in PBM audits, audit appeals, and network disputes. Our experienced PBM audit attorneys help pharmacy owners understand audit triggers, evaluate documentation risks, and develop legally grounded responses designed to protect reimbursement and preserve network participation.

If your pharmacy is facing a PBM audit, has received adverse audit findings, or is confronting a network termination notice, early legal involvement is critical. Contact Health Law Alliance today for a free consultation to learn how experienced healthcare defense counsel can help safeguard your pharmacy’s financial stability and long-term viability.